Steris | STE - Les Charges D'Exploitation





Les Charges D'Exploitation Changement Date
3M USD 4.89B 1.62B 2026-06
Accuray USD 37.18M 567K 2024-12
Avanos Medical USD 782.1M 625.97M 2026-03
Baxter International USD 6.04B 2.85B 2026-03
Becton, Dickinson and Co. USD 24.13B 19.54B 2026-03
Boston Scientific USD 4.15B 107M 2026-03
CONMED USD 291.63M 44.94M 2026-03
Cooper Companies USD 1.11B 301.2M 2026-03
Dexcom USD 936.6M 0 2026-03
Ecolab USD 3.39B 23M 2026-03
Edwards Lifesciences USD 1.13B 65.4M 2026-03
Fortive USD 877.7M 19.3M 2026-03
Getinge SEK 7.03B 2.96B 2026-06
Globus Medical USD 595.85M 49.26M 2026-03
Haemonetics USD 134.99M 1.26M 2025-12
Idexx Laboratories USD 778.23M 3.26M 2026-03
Inogen USD 49.14M 665K 2024-09
Insulet USD 639.7M 2.2M 2026-03
Integra LifeSciences USD 1.04B 673.49M 2026-03
Intuitive Surgical USD 1.91B 3.6M 2026-06
J&J USD 17.83B 388M 2026-06
Olympus JPY 268.42B 35.37B 2026-03
Orthofix International USD 213.79M 12.36M 2025-12
Owens Minor USD -464.76M 1.17B 2026-03
ResMed USD 925.74M 525K 2026-03
Steris USD 1.27B 51.5M 2026-03
Stryker USD 4.92B 284M 2026-03
Tandem Diabetes Care USD 282.09M 9.97M 2025-12
Teleflex USD 3.08B 2.55B 2026-03
Thermo Fisher Scientific USD 9.09B 821M 2026-03
Zimmer Biomet Holdings USD 1.69B 249.3M 2026-03